Bio-Techne Corporation develops, manufactures, and sells life science reagents and instruments for research and clinical diagnostic markets globally. The company operates two segments: Protein Sciences and Diagnostics and Genomics. Protein Sciences develops biological reagents used in life science research, diagnostics, and cell and gene therapy. This segment also offers proteomic analytical tools and immunoassays. Diagnostics and Genomics develops diagnostic products, including controls, calibrators, and diagnostic assays for regulated markets. The company sells instruments and process control products for various diagnostic applications.
| Indicator | Value |
|---|---|
| PER | 46.9 |
| EV/EBITDA | 23.2 |
| Price/Free Cash Flow' | 33.4 |
| ROIC | 12.0% |
| Net Debt/EBITDA | 0.8 |